Back to mobile site

CVS Health (CVS) Tops Q4 EPS by 14c; Trims Outlook

February 7, 2024 6:33 AM EST

CVS Health (NYSE: CVS) reported Q4 EPS of $2.12, $0.14 better than the analyst estimate of $1.98. Revenue for the quarter came in at $93.81 billion versus the consensus estimate of $90.25 billion.

GUIDANCE:

CVS Health sees FY2024 EPS of at least $8.30, versus its prior view of at least $8.50 and the consensus of $8.50.

For earnings history and earnings-related data on CVS Health (CVS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance

Related Entities

Earnings